Claybrook Capital’s Nomura Holdings NMR Stock Holding History

Claybrook Capital’s Portfolio NMR Stock Details NMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-318	Closed	-$1K	–	481
2018 Q4	$1K	Buy	+318	New	+$1.43K	﹤0.01%	721

Other funds holding NMR

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ECM

Evergreen Capital Management Bellevue, Washington $4.62B AUM 25.58% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Claybrook Capital's NMR Position: Q1 2019 in Review

Claybrook Capital sold out of Nomura Holdings (NMR) in Q1 2019, closing a stake of 318 shares — an estimated $1K sold.

Claybrook Capital first reported a position in NMR in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 93 funds tracked by Wall St. Rank hold NMR as of Q1 2019.

Claybrook Capital reported no remaining Nomura Holdings position as of Q1 2019 after selling out during the quarter.
Claybrook Capital sold 318 Nomura Holdings shares in Q1 2019, an estimated $1K.
Claybrook Capital first reported a position in Nomura Holdings in Q4 2018 and held it in 1 quarter.
Claybrook Capital's Nomura Holdings position peaked at $1K in Q4 2018.
93 funds tracked by Wall St. Rank held Nomura Holdings as of Q1 2019.

Based on Claybrook Capital's 13F filing for Q1 2019, filed 15 May 2019.